Low-grade inflammation is a major contributor of impaired attentional set shifting in obese subjects

Brain, Behavior, and Immunity

Volumn 58, Issue , 2016, Pages 63-68

  Lasselin, Julie ^a,b,c,d,e   Magne, Eric ^f,g   Beau, Cédric ^f,g   Aubert, Agnès ^a,b   Dexpert, Sandra ^a,b   Carrez, Julie ^a,b   Layé, Sophie ^a,b   Forestier, Damien ^f,g   Ledaguenel, Patrick ^f,g   Capuron, Lucile ^a,b  

^a NutriNeuro Bordeaux University   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

^e STOCKHOLM UNIVERSITY   (Sweden)

^f Clinique Tivoli   (France)

^g Clinique Jean Villar   (France)

Author keywords

Attentional set shifting; C reactive protein; Cognition; Cognitive flexibility; Low grade inflammation; Obesity

Indexed keywords

C REACTIVE PROTEIN; LEPTIN;

ADULT; ANALYTICAL ERROR; ARTICLE; ATTENTION DISTURBANCE; CAMBRIDGE NEUROPSYCHOLOGICAL TEST AUTOMATED BATTERY; CHRONIC INFLAMMATION; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; INTRA EXTRA DIMENSIONAL SET SHIFT TEST; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; OBESITY; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; TASK PERFORMANCE; ATTENTION; EXECUTIVE FUNCTION; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

ADULT; ATTENTION; C-REACTIVE PROTEIN; EXECUTIVE FUNCTION; FEMALE; HUMANS; INFLAMMATION; MALE; OBESITY;

EID: 84973922617     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2016.05.013     Document Type: Article

References (29)

1. Boeka, A.G., Lokken, K.L., Neuropsychological performance of a clinical sample of extremely obese individuals. Arch. Clin. Neuropsychol. 23 (2008), 467–474.
2. Capuron, L., Miller, A.H., Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther. 130 (2011), 226–238.
3. Castanon, N., Lasselin, J., Capuron, L., Neuropsychiatric comorbidity in obesity: role of inflammatory processes. Front. Endocrinol. (Lausanne), 5, 2014, 74.
4. Chaput, J.P., Leblanc, C., Perusse, L., Despres, J.P., Bouchard, C., Tremblay, A., Risk factors for adult overweight and obesity in the Quebec Family Study: have we been barking up the wrong tree?. Obesity (Silver Spring) 17 (2009), 1964–1970.
5. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9 (2008), 46–56.
6. Elias, M.F., Elias, P.K., Sullivan, L.M., Wolf, P.A., D'Agostino, R.B., Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int. J. Obes. Relat. Metab. Disord. 27 (2003), 260–268.
7. Fagundo, A.B., de la Torre, R., Jimenez-Murcia, S., Aguera, Z., Granero, R., Tarrega, S., Botella, C., Banos, R., Fernandez-Real, J.M., Rodriguez, R., Forcano, L., Fruhbeck, G., Gomez-Ambrosi, J., Tinahones, F.J., Fernandez-Garcia, J.C., Casanueva, F.F., Fernandez-Aranda, F., Executive functions profile in extreme eating/weight conditions: from anorexia nervosa to obesity. PLoS ONE, 7, 2012, e43382.
8. Fain, J.N., Madan, A.K., Hiler, M.L., Cheema, P., Bahouth, S.W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145 (2004), 2273–2282.
9. Gunstad, J., Bausserman, L., Paul, R.H., Tate, D.F., Hoth, K., Poppas, A., Jefferson, A.L., Cohen, R.A., C-reactive protein, but not homocysteine, is related to cognitive dysfunction in older adults with cardiovascular disease. J Clin Neurosci 13 (2006), 540–546.
10. Gunstad, J., Paul, R.H., Cohen, R.A., Tate, D.F., Spitznagel, M.B., Gordon, E., Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr. Psychiatry 48 (2007), 57–61.
11. Hampshire, A., Owen, A.M., Fractionating attentional control using event-related fMRI. Cereb. Cortex 16 (2006), 1679–1689.
12. Hays, N.P., Roberts, S.B., Aspects of eating behaviors “disinhibition” and “restraint” are related to weight gain and BMI in women. Obesity (Silver Spring) 16 (2008), 52–58.
13. Lasselin, J., Capuron, L., Chronic low-grade inflammation in metabolic disorders: relevance for behavioral symptoms. NeuroImmunoModulation 21 (2014), 95–101.
14. Lokken, K.L., Boeka, A.G., Yellumahanthi, K., Wesley, M., Clements, R.H., Cognitive performance of morbidly obese patients seeking bariatric surgery. Am. Surg. 76 (2010), 55–59.
15. Mangiafico, R.A., Sarnataro, F., Mangiafico, M., Fiore, C.E., Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels. Age Ageing 35 (2006), 60–65.
16. Marioni, R.E., Stewart, M.C., Murray, G.D., Deary, I.J., Fowkes, F.G., Lowe, G.D., Rumley, A., Price, J.F., Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia. Psychosom. Med. 71 (2009), 901–906.
17. Marioni, R.E., Strachan, M.W., Reynolds, R.M., Lowe, G.D., Mitchell, R.J., Fowkes, F.G., Frier, B.M., Lee, A.J., Butcher, I., Rumley, A., Murray, G.D., Deary, I.J., Price, J.F., Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 59 (2010), 710–713.
18. Marsland, A.L., Petersen, K.L., Sathanoori, R., Muldoon, M.F., Neumann, S.A., Ryan, C., Flory, J.D., Manuck, S.B., Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. Psychosom. Med. 68 (2006), 895–903.
19. Monchi, O., Petrides, M., Petre, V., Worsley, K., Dagher, A., Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J. Neurosci. 21 (2001), 7733–7741.
20. Park, H.S., Park, J.Y., Yu, R., Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res. Clin. Pract. 69 (2005), 29–35.
21. Raison, C.L., Capuron, L., Miller, A.H., Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27 (2006), 24–31.
22. Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., Haroon, E., Miller, A.H., A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70 (2013), 31–41.
23. Sahakian, B.J., Owen, A.M., Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J. R. Soc. Med. 85 (1992), 399–402.
24. Stilley, C.S., Bender, C.M., Dunbar-Jacob, J., Sereika, S., Ryan, C.M., The impact of cognitive function on medication management: three studies. Health Psychol. 29 (2010), 50–55.
25. Sweat, V., Starr, V., Bruehl, H., Arentoft, A., Tirsi, A., Javier, E., Convit, A., C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation 31 (2008), 198–207.
26. Visser, M., Bouter, L.M., McQuillan, G.M., Wener, M.H., Harris, T.B., Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999), 2131–2135.
27. Wellen, K.E., Hotamisligil, G.S., Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112 (2003), 1785–1788.
28. Westenhoefer, J., Broeckmann, P., Munch, A.K., Pudel, V., Cognitive control of eating behaviour and the disinhibition effect. Appetite 23 (1994), 27–41.
29. Wu, M., Brockmeyer, T., Hartmann, M., Skunde, M., Herzog, W., Friederich, H.C., Set-shifting ability across the spectrum of eating disorders and in overweight and obesity: a systematic review and meta-analysis. Psychol. Med. 44 (2014), 3365–3385.